Pieter Rottiers

Company: Precigen ActoBio

Job title: CEO

Seminars:

Bacteria-Based Therapeutic Agents Designed to Modulate the Body’s Immune System Towards Antigen-Specific Immune Tolerance 11:30 am

Introducing the bacteria-based therapeutics platform for delivery of biologics directly to the gut Showcasing its potential to modulate the body's immune system towards antigen-specific immune tolerance Highlighting the phase 1b/2a study results in recent-onset Type 1 DiabetesRead more

day: Conference Day Two